NCT00100269View on ClinicalTrials.gov

Menevit Study: Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

March 31, 2006

Conditions
Infertility, MaleOxidative Stress
Interventions
DRUG

Menevit anti-oxidant

Trial Locations (1)

5065

Repromed, Adelaide

All Listed Sponsors
lead

Repromed

OTHER

NCT00100269 - Menevit Study: Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility | Biotech Hunter | Biotech Hunter